Marshall Woodworth
2023
In 2023, Marshall Woodworth earned a total compensation of $154.5K as Chief Financial Officer at NeuroBo Pharmaceuticals.
Compensation breakdown
| Other | $154,500 |
|---|---|
| Total | $154,500 |
Woodworth received $154.5K in other compensation, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Marshall Woodworth's compensation ranked 2,831st out of 2,983 executives tracked by ExecPay. In other words, Woodworth earned more than 5.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,831 out of 2,983 | 5th |
Division Manufacturing | 1,568 out of 1,637 | 4th |
Major group Chemicals And Allied Products | 870 out of 906 | 4th |
Industry group Drugs | 840 out of 869 | 3rd |
Industry Pharmaceutical Preparations | 604 out of 627 | 4th |
Source: SEC filing on April 30, 2024.
Woodworth's colleagues
We found three more compensation records of executives who worked with Marshall Woodworth at NeuroBo Pharmaceuticals in 2023.